Chinese Authorities Release More Sordid Glaxo Scandal Details
Latest FDA and cGMP Compliance News There have been more developments in the bribery/sex scandal in China involving GlaxoSmithKline. GSK has now put Herve Gisserot, the senior vice president of its business in Europe, as the head of operations in China. His predecessor, Mark Reilly, is going to return to China in the next few […]
Read More »Category : News
Glaxo Telling Muddled Stories on Chinese Bribery Scandal
Latest FDA and cGMP Compliance News For the last month, GlaxoSmithKline officials have tried to look contrite and diligent as they try to control the damage from the massive bribery scandal in China. There, four senior employees were detained by authorities for allegedly participating in a scheme that involved paying hundreds of millions of […]
Read More »Category : News
IMS Health Accused of Eliminating Competition to Gain Monopoly
Latest FDA and cGMP Compliance News IMS Health is probably the leading company in the collection of data in the pharmaceutical industry. However, that company has a smaller rival, Symphony Health Solutions, that is now claiming that IMS has increased revenues and its base of customers illegally, the goal being to obtain a monopoly in […]
Read More »Category : News
Did Glaxo Violate Corporate Integrity Agreement With China Trainwreck of Scandal?
Latest FDA and cGMP Compliance News The continuing train wreck of scandals at GlaxoSmithKline in China, such as bribes done by senior executives and clinical study failures, have led to investor anxiety, but shares are largely trading in the same range as before all the trouble started in May. GSK has said it is not […]
Read More »Category : News
PhRMA Ranked as Top Lobbying Group in DC – What Say You?
Latest FDA and cGMP Compliance News Many policymakers in DC think that the pharma industry is definitely getting its money’s worth for the dues they hand to PhRMA, the drug industry trade group. A recent survey of 500 policymakers in DC stated that the Pharmaceutical Research and Manufacturers of America is the best in 4 […]
Read More »Category : News
The Glaxo China Scandal – Bribes, Hidden Study Results and More
Latest FDA and cGMP Compliance News There are serious signs that the R&D operations in China for GlaxoSmithKline are a complete train wreck. The latest story is that researchers were failing to report animal study results on drugs that were being tested in humans, and employees failed to monitor clinical studies and they paid […]
Read More »Category : News
Urine Puddles and Destroyed Records – FDA Hits Wockhardt Hard In Latest Warning Letter
Latest FDA and cGMP Compliance News Over the years, we have seen a number of FDA warning letters that have some rather alarming and sometimes even amusing details about cGMP violations. But the warning letter that Wockhardt received on July 18 had some truly unusual practices and violations noted that are going to be watched […]
Read More »Category : News
Mallinckrodt Shells Out $3.5 Million to Settle Kickback Probe in Whistleblower Case
Latest FDA and cGMP Compliance News Just three days after the DOJ engaged in a whistleblower suit against the drug company Mallinckrodt, the firm agreed to a fine of $.35 million to settle the charges that it paid out kickbacks to doctors to encourage them to prescribe drugs. This illegal activity caused both the Medicare […]
Read More »Category : News
Damage Spreads for Glaxo in China Bribery Scandal – Execs Oversaw Bribes
Latest FDA and cGMP Compliance News More fallout is coming for GlaxoSmithKline in the bribery scandal mess in China. This past weekend, the drug company was scrambling on multiple fronts to limit the damage from the bribery scandal. The president of international operations, Abbas Hussain, met with authorities in China and issued a formal statement, […]
Read More »Category : News
Eli Lilly Enacts Pay Raise Freeze for Employees
Latest FDA and cGMP Compliance News A few months after it announced plans to lay off 1700 sales reps, Eli Lilly is going to suspend pay raises for the vast majority of employees in 2014, including executives and managers. It also is going to cut employee bonuses that are supposed to be paid out in […]
Read More »Category : News
